FibroGen Correlations

FGEN Stock  USD 0.45  0.01  2.27%   
The current 90-days correlation between FibroGen and Ardelyx is -0.14 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FibroGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FibroGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

FibroGen Correlation With Market

Average diversification

The correlation between FibroGen and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.

Moving together with FibroGen Stock

  0.7VTGN VistaGen TherapeuticsPairCorr

Moving against FibroGen Stock

  0.33DVAX Dynavax TechnologiesPairCorr
  0.43CDTTW Conduit PharmaceuticalsPairCorr
  0.39VRTX Vertex PharmaceuticalsPairCorr
  0.34VNDA Vanda PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
MREOZURA
HEPAZURA
MREOHEPA
DAWNMREO
DAWNZURA
DAWNHEPA
  
High negative correlations   
BMRNBPMC
BMRNDAWN
VSTMZURA
DAWNVSTM
VSTMHEPA
MREOVSTM

Risk-Adjusted Indicators

There is a big difference between FibroGen Stock performing well and FibroGen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze FibroGen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ARDX  3.22  0.19  0.03  0.02  4.41 
 8.32 
 27.51 
ZURA  4.77 (0.78) 0.00 (0.44) 0.00 
 9.79 
 29.06 
HEPA  9.71 (3.54) 0.00 (6.46) 0.00 
 17.65 
 86.86 
AVRO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
VSTM  4.38  0.53  0.14 (5.53) 4.20 
 7.86 
 50.66 
MREO  2.56 (0.42) 0.00 (0.74) 0.00 
 6.16 
 20.77 
BPMC  2.08  0.06  0.00 (0.06) 0.00 
 5.39 
 26.30 
AGIO  2.77 (0.89) 0.00 (1.50) 0.00 
 4.19 
 21.09 
DAWN  2.69 (0.65) 0.00 (1.01) 0.00 
 4.59 
 22.86 
BMRN  1.14  0.07  0.09  2.43  1.70 
 2.95 
 8.07 

FibroGen Corporate Management

Kirk MBAChief OfficerProfile
Rahul KaushikTechnical DevelopmentProfile
Mr JDChief OfficerProfile
Enrique ConternoCEO DirectorProfile
Barry BerkowitzFounderProfile
Christine ChungSenior OperationsProfile
David DeLuciaVice RelationsProfile